Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Biotechnology

Healthcare
$39.15 +8.79%

+$2.32 today

Market cap
$1.83B
Beta
0.00
52W Low $23.00High $36.61

Volume 0.30M

Average 0.34M

Price history

Hemab Therapeutics Holdings, Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+15.15%

Period high

$54.94

Period low

$24.98

Latest

$39.15

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
SC 13G/ANov 6, 2026Nov 6, 2026
4Sep 25, 2026Sep 25, 2026
3Sep 25, 2026Sep 25, 2026
8-KSep 24, 2026Sep 24, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13GAug 12, 2026Aug 12, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
SC 13GAug 7, 2026Aug 7, 2026
SC 13GAug 6, 2026Aug 6, 2026
SC 13GAug 5, 2026Aug 5, 2026
4Jun 17, 2026Jun 17, 2026

Competitors

Who does Hemab Therapeutics Holdings, Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about COAG's filings, answered from its disclosures.

What is the latest COAG filing?

The latest filing shown is 8-K dated Nov 10, 2026.

How many recent filings does COAG have?

Intrinsic Alpha currently shows 20 recent filings for COAG.